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Due to enhanced energy content and reduced hygroscopicity compared with ethanol, 
n-butanol is flagged as the next generation biofuel and platform chemical. In addition to 
conventional cellular systems, n-butanol bioproduction by enzyme cascades is gaining 
momentum due to simplified process control. In contrast to other bio-based alcohols 
like ethanol and isobutanol, cell-free n-butanol biosynthesis from the central metabolic 
intermediate pyruvate involves cofactors [NAD(P)H, CoA] and acetyl-CoA-dependent 
intermediates, which complicates redox and energy balancing of the reaction system. 
We have devised a biochemical process for cell-free n-butanol production that only 
involves three enzyme activities, thereby eliminating the need for acetyl-CoA. Instead, 
the process utilizes only NADH as the sole redox mediator. Central to this new process is 
the amino acid catalyzed enamine–aldol condensation, which transforms acetaldehyde 
directly into crotonaldehyde. Subsequently, crotonaldehyde is reduced to n-butanol 
applying a 2-enoate reductase and an alcohol dehydrogenase, respectively. In essence, 
we achieved conversion of the platform intermediate pyruvate to n-butanol utilizing a 
biocatalytic cascade comprising only three enzyme activities and NADH as reducing 
equivalent. With reference to previously reported cell-free n-butanol reaction cascades, 
we have eliminated five enzyme activities and the requirement of CoA as cofactor. Our 
proof-of-concept demonstrates that n-butanol was synthesized at neutral pH and 50°C. 
This integrated reaction concept allowed GC detection of all reaction intermediates and 
n-butanol production of 148 mg L−1 (2 mM), which compares well with other cell-free 
n-butanol production processes.
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inTrODUcTiOn
n-Butanol is a primary 4-carbon alcohol, which is flagged as the next generation biofuel and platform 
chemical due to its enhanced energy content and reduced hygroscopicity compared with ethanol 
(Li et al., 2010). n-Butanol is of interest as a platform chemical in the chemical, textile, polymer, and 
biofuel industry (Dürre, 2007).
Conventionally, biotechnological n-butanol production is based on the anaerobic ABE fermen-
tation process, which utilizes solventogenic Clostridia strains, such as Clostridium acetobutylicum 
(Lin and Blaschek, 1983; Vollherbst-Schneck et  al., 1984; Dusseaux et  al., 2013). However, this 
FigUre 1 | schematic illustration of the n-butanol reaction cascade 
via the enamine–aldol condensation. PDC, pyruvate decarboxylase; Pro, 
proline; YqjM, 2-enoate reductase; ADH, alcohol dehydrogenase.
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process involves formation of several undesired by-products (i.e., 
butyrate) (Lee et al., 2008).
In contrast to cell-based production systems, the recent appli-
cation of artificial, solvent tolerant enzyme cascades provides 
opportunities for targeted in  vitro biobutanol production that 
allow operation at higher process temperatures. Exemplary, we 
previously established a modular, in  vitro enzyme cascade that 
allows the flexible conversion of glucose to either ethanol or 
isobutanol at 50°C, respectively (Guterl et al., 2012). This enzyme 
system is based on an artificial glycolytic reaction cascade that 
utilizes pyruvate as the central intermediate.
In contrast to the in vitro ethanol and isobutanol production 
system, the design of an n-butanol-specific enzyme cascade is 
more complex and involves several bottlenecks, multiple coen-
zyme A (CoA)-dependent intermediates and unstable cofactors. 
The natural clostridial n-butanol biosynthesis from glucose 
comprises 16 enzyme activities, 5 CoA-dependent intermediates, 
3 cofactors, and several ATP-dependent conversion steps (Inui 
et  al., 2008; Bar-Even et  al., 2012; Krutsakorn et  al., 2013). At 
present, an in  vitro enzyme cascade for n-butanol production 
from glucose has been described, which in analogy to the cell-
based system involves 16 different enzyme activities for glycolysis 
and an artificial solventogenesis utilizing thermostable enzyme 
variants (Krutsakorn et al., 2013). Notably, the reaction cascade 
primarily focused on converting pyruvate to n-butanol utilizing 
seven enzyme activities, CoA and NADH as cofactors. In this 
approach, unbalanced concentrations of CoA-dependent inter-
mediates and generated NAD+ inhibit crucial enzyme activities, 
such as a crotonase similar 3-hydroxypropionyl-CoA dehydratase, 
thiolase, and β-hydroxybutyryl-CoA dehydrogenase, thereby 
limiting product yield (Engel et al., 1996; Sommer et al., 2013a; 
Reisse et al., 2014). In order to sustain in vitro n-butanol biosyn-
thesis in the presence of CoA and NAD+, therefore, required a 
time-dependent feeding of metabolic intermediates to overcome 
enzyme-specific feedback inhibition and temperature-dependent 
cofactor instability (Krutsakorn et al., 2013). In general, manag-
ing the cofactor balance and adjusting a linear production rate 
is very difficult considering that complete inhibition of a single 
enzyme activity would arrest the entire process. Furthermore, 
ATP is unstable under extended process times and at elevated 
temperatures. In addition, controlling the stoichiometry of 
various CoA-dependent intermediates requires constant feeding 
during the reaction, which increases process complexity and cost.
In this study, we have focused on establishing an in  vitro 
n-butanol production process from pyruvate at elevated tem-
peratures. This cell-free process is minimized with respect to 
employed enzyme activities. In comparison to previous studies, 
we achieved to entirely eliminate all ATP and CoA-dependent 
reactions using NADH as the sole redox shuttle. Our study has 
focused on conversion of pyruvate to n-butanol, as there are now 
several efficient cell-based (Xu et al., 2008) and in vitro routes (Gao 
et al., 2009; Guterl et al., 2012) for the production of this platform 
metabolite available. We have chosen a reaction temperature of 
50°C to be compatible with our previous study describing the 
cell-free conversion of glucose to pyruvate (Guterl et al., 2012).
The realization of our in  vitro biocatalytic reaction cascade 
predominantly relies on the substitution of CoA-dependent 
reaction steps by an organocatalyst, such as an amino acid or 
diamine, which facilitates the direct conversion of acetaldehyde 
to crotonaldehyde by an enamine–aldol condensation (List, 
2002). The implementation of this enamine condensation now 
enables the bypass of the native n-butanol pathway enzymes, 
such as CoA-acetylating aldehyde dehydrogenase, thiolase, 
hydroxybutyryl-CoA dehydrogenase, crotonase, and butyryl-
CoA dehydrogenase. This approach provides direct access to an 
alternative n-butanol cascade, which we postulated previously 
(Sommer et al., 2013b). The resulting in vitro biocatalytic reaction 
cascade is the first report of an artificially designed thermotolerant 
and highly condensed n-butanol biosynthesis route (Figure 1).
FigUre 2 | catalytic cycle of the enamine–aldol condensation of acetaldehyde, applying the catalyst proline.
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The primary conversion involves the pyruvate decarboxylase 
(PDC) to acetaldehyde, which in turn serves as a substrate for 
the biochemically catalyzed enamine–aldol condensation, utiliz-
ing amino acids (i.e., proline) or natural diamines as a catalyst 
(Figure 2).
In this respect, proline is unique due to its pyrrolidine 
moiety, which translates to a pronounced nucleophilic reactiv-
ity. While the pyrrolidine moiety readily forms iminium ions 
and enamines (List, 2002), amino acids, such as arginine or 
tryptophan, featuring a secondary amine moiety can serve as 
suitable catalysts. Moreover, natural polyamines, such as sper-
midine or putrescine, show the desired catalytic capacity albeit 
at lower reactivity compared with the former (Theruvathu 
et  al., 2005).
In a subsequent two-step reaction, the resulting crotonalde-
hyde is converted to butyraldehyde and finally to n-butanol by 
action of a 2-enoate reductase (YqjM) and an alcohol dehydroge-
nase (ADH) (Sommer et al., 2013b).
Consequently, our designed biocatalytic n-butanol produc-
tion cascade is consolidated to use only three enzyme activities, 
an amino acid with secondary amine functionality and NADH 
as reducing equivalent. With reference to previously reported 
in  vitro n-butanol reaction cascades, we have eliminated five 
enzyme activities, the requirement of ATP and CoA as a cofactor 
as well as five CoA-dependent intermediates.
MaTerials anD MeThODs
chemicals
All chemicals were purchased in analytical grade from Sigma-
Aldrich (Munich, Germany) and Carl Roth (Karlsruhe, Germany).
enzyme selection
Pyruvate decarboxylase (Zymomonas mobilis) and YqjM (Bacillus 
subtilis) were selected due to their established catalytic perfor-
mance at the desired reaction conditions (50°C, neutral pH). 
Moreover, both enzyme systems have previously been used in 
our cell-free solvent production cascades (Guterl et  al., 2012; 
Sommer et al., 2013b). As our experimental approach focused on 
the application of non-commercial enzymes, we have integrated 
an alternative ADH from Geobacillus stearothermophilus. Data 
characterizing this enzyme are presented in this study.
cloning
The cloning procedures for plasmids containing PDC and YqjM 
followed literature protocols (Guterl et al., 2012; Sommer et al., 
2013b). A codon-optimized variant of the ADH gene (ADH-HT, 
NCBI accession number: CAA81612.1) was synthesized by Life 
Technologies (Regensburg, Germany). The artificial gene was 
cloned into the Escherichia coli-compatible vector pET-22b 
(Merck, Darmstadt, Germany) with C-terminal His-Tag via NdeI 
and XhoI restriction sites.
enzyme Preparation
Enzyme expression was performed using E. coli BL21 (DE3) or 
HMS173 (DE3) (Novagen, Nottingham, UK) as host strains. 
Cultivations were carried out in shake flask cultures or in a 
10-L Biostat C plus bioreactor (Sartorius Stedim, Göttingen, 
Germany). Recombinant cells were initially cultivated at 37°C 
in TB medium supplemented with kanamycin (30–50 μg mL−1), 
unless otherwise stated. The cells were induced with 1  mM 
isopropyl-β-d-thiogalactopyranoside (IPTG) at OD600 0.5–0.8. 
Cultures were subsequently harvested and frozen at −20°C until 
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further use. PDC was expressed in Zyp-5052 (Studier, 2005), YqjM 
in TB medium. After induction with IPTG, growing temperatures 
were lowered at 30 or 25°C. ADH was expressed in a fed-batch 
cultivation method at 37°C using LB as medium supplemented 
with 0.25 mM ZnSO4 and 100 μg mL−1 ampicillin. The cells were 
induced with 0.3 mM IPTG at OD600 = 5 and further cultivated 
for 4 h before harvest and storage at −20°C.
Cell lysates were prepared with an Emulsiflex-B15 (Avestin, 
Mannheim, Germany). Cell debris and protein aggregates were 
separated from the soluble fraction by centrifugation (21,000 × g, 
4°C, 20 min). The enzymes were purified (50 mM HEPES buffer, 
pH 7) via immobilized metal affinity chromatography (IMAC) 
using a NGC FPLC-system (Bio-Rad, Munich, Germany) 
equipped with a HisTrap FF column (GE Healthcare, Freiburg, 
Germany). Purified enzyme solutions were desalted using a 
HiPrep 26/10 Desalting-column (Bio-Rad) in 50 mM HEPES pH 
7 plus 10% glycerol for subsequent storage at −80°C.
enzyme assays
Baseline Spectrophotometric ADH Characterization
The baseline characterization of ADH was conducted photomet-
rically in 96-well microtiter plate format using a Varioskan pho-
tometer (Thermo Scientific, Braunschweig, Germany). Reactions 
using NADH as cofactor could be monitored at 340 nm (molar 
extinction coefficient NADH = 6.22 L mmol−1 cm−1). Activities 
were measured by following the NADH-dependent reduction of 
aldehydes to the corresponding alcohols in 100 mM HEPES buffer 
(pH 7) and 2.5 mM MgSO4 at 50°C, unless otherwise stated.
Optimum temperature and pH were determined by monitor-
ing reduction rates of 1 mM acetaldehyde with 0.3 mM NADH 
at different temperatures (30–70°C) and in different buffers 
(sodium phosphate pH 5.5–6.5, HEPES pH 6.5–7, and TRIS pH 
7–8), respectively. Thermal stability was tested by measuring 
ADH activity after different incubation times (0–24  h) at 50, 
60, and 70°C. ADH kinetic parameters were determined with 
0.3  mM NADH and varying concentrations of acetaldehyde 
(0.01–0.14 mM) or butyraldehyde (0.8–3 mM).
Enzyme Assays for n-Butanol Cascade Design
For the reaction cascade design, all enzyme activities (PDC, 
YqjM, and ADH) were determined under comparable reaction 
conditions and analyzed using a Thermo Scientific Trace GC 
Ultra gas chromatograph with flame ionization detector (FID). 
Reaction mixtures were incubated in a 2-mL GC-Vial at 50°C in 
a water bath for accurate temperature control, whereby the pH 
was adjusted to the corresponding temperature. The reaction was 
stopped at several time points with 7% trichloroacetic acid (TCA).
PDC Assay
The PDC was measured in an assay mixture containing 50 mM 
HEPES buffer (pH 7), 20 mM sodium pyruvate, 2.5 mM MgSO4, 
and 0.1 mM thiamine pyrophosphate (TPP). The reaction prod-
ucts were analyzed by GC measurements.
YqjM Assay
2-Enoate reductase activity was measured in a coupled assay 
using a horse liver ADH (Evocatal GmbH, Monheim, Germany). 
The reaction was carried out at 50°C (t =  30  min) in 50  mM 
HEPES buffer (pH 7) containing 2.5 mM MgSO4, 0.05 mM FMN, 
and 20 mM NADH as cofactors and 20 mM crotonaldehyde. The 
reaction products were analyzed by GC measurements.
ADH Assay
Alcohol dehydrogenase activity was determined in 50 mM HEPES 
buffer (pH 7) with 2.5 mM MgSO4 and 20 mM butyraldehyde or 
acetaldehyde.
One unit of enzyme activity corresponds to the amount of 
enzyme, which reduces 1 μmol substrate per minute.
enamine–aldol condensation
Potential catalysts for the enamine–aldol condensation were 
screened with a dose of 20  mM in 2  mL GC vials containing 
20  mM acetaldehyde and 50  mM HEPES buffer (pH 7). The 
vials were incubated in a water bath at 50°C for up to 3 h and 
subsequently analyzed via GC. The reactions were stopped with 
7% TCA.
In particular, the proline reaction was thoroughly examined 
with respect to its temperature (40–90°C), pH (5.5–10), and 
concentration (1–500  mM) dependency. The pH dependency 
was measured either in a 50 mM MES (pH 5.5–6.5), HEPES (pH 
7–8), TAPS (pH 9), or CAPS (pH 10) buffer system, respectively.
Baseline characterization and 
Optimization of the reaction system
Required enzyme quantities for the cell-free n-butanol produc-
tion were calculated based on the previous reference measure-
ments for individual unit activities: PDC = 72.8 ± 0.9 U mL−1 
(toward pyruvate), YqjM = 1.1 ± 0.1 U mL−1 (toward crotonalde-
hyde), ADH = 4592 ± 65.7 U mL−1 (toward acetaldehyde), and 
183.1 ±  3.7  U  mL−1 (toward butyraldehyde). The proline dose 
was calculated based on previous control experiments carried out 
with different proline concentrations.
Optimizing the Reaction System
To determine the optimal biocatalyst composition, various 
reaction designs were examined. All reaction mixtures comprise 
20 mM pyruvate, 0.05 mM FMN, 20 mM NADH, 2.5 mM MgSO4, 
and 0.1 mM TPP in 50 mM HEPES buffer (pH 7). To determine 
the optimal enzyme activity ratios different reaction designs 
were examined: Reaction 1: 0.25 U mL−1 PDC, YqjM, ADH, and 
0.5 U mL−1 proline; Reaction 2: 0.5 U mL−1 PDC, proline, and 
0.25 U mL−1 YqjM, ADH; Reaction 3: 0.5 U mL−1 PDC, YqjM, 
ADH, and proline; Reaction 4: 0.5 U mL−1 PDC, YqjM, ADH, and 
0.25 U mL−1 proline. Reactions were carried out at 50°C without 
stirring over 10 h.
Starting with pyruvate, the whole production cascade was 
eventually screened in triplicate in 2 mL GC vials. All required 
biocatalysts and their ligands are stated in Table 1. The reaction 
mixture contained 20 mM pyruvate, 319 mM proline, 0.05 mM 
FMN, 20  mM NADH, 2.5  mM MgSO4, and 0.1  mM TPP in 
50 mM HEPES buffer (pH 7). The final acetaldehyde conversion 
rate was set to 0.25 U mL−1. To initiate the reaction, an enzyme 
mixture containing 0.5  U  mL−1 PDC, 0.5  U  mL−1 YqjM, and 
0.5 U mL−1 ADH (toward butyraldehyde) was added to each vial. 
TaBle 1 | required biocatalysts to generate n-butanol from pyruvate.
# Biocatalyst ec # substrate Product
1 Pyruvate decarboxylase  
(PDC)
4.1.1.1 Pyruvate Acetaldehyde
2 Proline – Acetaldehyde Crotonaldehyde
3 2-enoate reductase (YqjM) 1.3.1.31 Crotonaldehyde Butyraldehyde
4 Alcohol dehydrogenase (ADH) 1.1.1.1 Butyraldehyde n-Butanol
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Control reactions were performed without enzyme addition. The 
vials were placed in a water bath and incubated at 50°C without 
stirring. Samples were collected at constant 2  h time intervals 
over 10 h. Reactions were stopped for GC analysis by addition of 
7% TCA. Samples for high-performance liquid chromatography 
(HPLC) analysis were pretreated by filtration (10 kDa MWCO 
Zentrifugal Filter, VWR, Darmstadt, Germany). Collected sam-
ples were subsequently analyzed via GC and HPLC to determine 
the product and intermediates.
analytical Methods
Aldehydes and alcohols were separated and quantified by gas 
chromatography using Trace GC Ultra (Thermo Scientific, 
Braunschweig, Germany), equipped with Headspace Tri Plus 
autosampler, an agitator and FID. All compounds were separated 
via a Stabilwax column (length 30 m, 0.25 mm internal diameter, 
0.25 μm film thickness; Restek, Bad Homburg, Germany), with 
helium (1.2 mL min−1) as carrier gas. The oven temperature was 
programed to be held at 50°C for 2 min, raised with a ramp of 
10 to 200°C  min−1 and held for 1  min. Injector and detector 
were kept at 200°C. Samples were incubated prior to injection at 
40°C for 15 min. For the analysis, 700 μL of the headspace were 
injected (headspace syringe 100°C) in the split mode with a flow 
of 10 mL min−1.
Pyruvate was separated and quantified via HPLC, using an 
Ultimate-3000 HPLC-system (Thermo Scientific, Braunschweig, 
Germany), equipped with an autosampler, a thermostatic column 
compartment, and a diode-array detector. The separation was 
achieved on a Metrosep Supp A16 column (25 mm, particle size 
4.6 μm; Metrohm, Filderstadt, Germany) at 65°C by isocratic elu-
tion with 12 mM ammonium bicarbonate (pH 10), followed by 
a washing step with 30 mM sodium carbonate (pH 10.4). Mobile 
phase flow was adjusted to 0.2 mL min−1.
resUlTs
evaluation of Potential catalysts for the 
enamine–aldol condensation
Potential catalysts for the desired enamine condensation were 
selected and tested with acetaldehyde in 50 mM HEPES buffer 
(pH 7) at 50°C for maximal 3  h. The selected panel of natural 
organocatalysts comprises the amino acids arginine and proline 
as well as the polyamine spermidine. The amino acid alanine 
served as a negative control. While proline (List, 2002) was 
reported to harbor the desired nucleophilic reactivity, arginine 
was selected due to the secondary amine function that comprises 
its side chain. As spermidine also possesses secondary amines, it 
also represents potential catalytic candidate (Theruvathu et  al., 
2005).
Proline displayed the best conversion rate of acetaldehyde to 
crotonaldehyde with 5.7 ± 0.2 × 10−3 μmol min−1 mL−1 (Figure 3). 
With respect to the proline reaction rate, arginine and the poly-
amine spermidine accomplished 46% of the reference value. As 
expected, the negative control alanine showed only 4% of the 
proline activity (Table 2).
Optimizing reaction conditions
To establish the new n-butanol cascade proline was selected and 
further examined regarding temperature, pH, and concentra-
tion. Thereby, our standard reaction conditions (20 mM proline, 
50 mM HEPES, pH 7 at 50°C) were adapted to the corresponding 
experiments.
The operational temperature dependency was determined 
by incubating the proline reaction mix between 40 and 90°C. 
The formation of crotonaldehyde was subsequently monitored 
via GC-FID. As illustrated in Figure  4A, the proline activity 
was simultaneously rising with the temperature and could be 
increased tenfold from 50 to 90°C.
Determination of pH effects on the proline reactivity were 
studied at 50°C. The proline activity over a broad pH range was 
evaluated with each 50  mM MES (pH 5.5–6.5), HEPES (pH 
7–8), TAPS (pH 9), and CAPS (pH 10) buffer, respectively. We 
could measure a significant increase in activity with increasing 
pH (Figure 4B). Notably, the proline activity at pH 10 was over 
100-fold higher than at neutral pH.
As the organocatalyst concentration is a key process parameter, 
we have determined the aldol condensation in the presence of 
increasing proline concentrations (Figure 4C). The highest detect-
able proline activity was 494.6 ±  4.6 ×  10−3 μmol  min−1  mL−1  
at 500 mM. With the provided data, proline could be set to specific 
conversion rates to achieve an optimal n-butanol production.
Although the proline-catalyzed aldol condensation favors 
higher pH and temperature values, the overall reaction condi-
tions were set to 50°C and neutral pH with respect to the enzymes 
characteristics of ADH, PDC, and YqjM. While ADH accepted 
higher temperatures over 60°C (Table  3), PDC and YqjM 
preferred temperatures in the range of 50°C or less. All three 
enzymes additionally operated optimal at neutral or slightly 
acidic conditions (Gocke et al., 2007; Guterl et al., 2012; Sommer 
et al., 2013b).
Considering this pathway composition and the upstream 
glycolytic reaction module (Guterl et al., 2012), the chosen reac-
tion parameters represent a feasible compromise that maintains 
activity for all required catalytic components albeit not operating 
at their individual optimum.
In Vitro n-Butanol synthesis
The consolidated conversion of pyruvate to n-butanol was car-
ried out at 50°C for 10  h and neutral pH conditions. Proline 
was applied as an organocatalyst for the desired enamine–aldol 
condensation due to its superior reaction rate compared with 
other evaluated amines. All reaction intermediates and products 
were quantified with authentic standards using established GC 
and HPLC protocols.
FigUre 3 | conversion of acetaldehyde to crotonaldehyde via proline. (a) Separate control measurements: - - 20 mM acetaldehyde; ⋅⋅⋅⋅⋅⋅ 20 mM 
crotonaldehyde. (B) Crotonaldehyde biosynthesis. The reaction (–––) was carried out at 50°C in 50 mM HEPES buffer (pH 7) with 20 mM acetaldehyde as substrate.
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Initially, various reaction designs were examined in single 
tests to identify the optimal organo-/biocatalyst composition. 
Therefore, different enzyme and proline activities were evalu-
ated and compared, as illustrated in Figure S1 in Supplementary 
Material. The GC data indicated that our designed in  vitro 
biocatalytic reaction cascade allows the direct conversion of 
pyruvate to n-butanol. The best result of 2  mM n-butanol was 
obtained by the combination of 0.5 U mL−1 PDC, YqjM, ADH, 
and 0.25 U mL−1 proline.
Subsequently, the reaction cascade was then tested in triplicate, 
whereby each independent experiment was triggered by addition 
of the enzyme mix leading to the formation of 2.0 ±  0.0  mM 
n-butanol (Figure 5). The n-butanol production rate remained 
constant during the first 4 h and achieved a production rate of 
TaBle 2 | conversion rates for the transformation of acetaldehyde to 
crotonaldehyde.
Organocatalyst v (μmol min−1 ml−1)
Proline 5.7 ± 0.2 × 10−3
Arginine 2.6 ± 0.1 × 10−3
Spermidine 2.6 ± 0.0 × 10−3
Alanine 0.2 ± 0.0 × 10−3
All organocatalysts were tested at a concentration of 20 mM at 50°C in 50 mM HEPES 
buffer (pH 7), containing 20 mM acetaldehyde.
TaBle 3 | Geobacillus stearothermophilus aDh characteristics.
Parameter Value
Optimum temperature 60°C
Thermal stability (50°C) t/2 ≥ 24 h
Thermal stability (60°C) t/2 = 12 h
Thermal stability (70°C) t/2 = 2 h
Optimum pH 6
pH range 5.5–8
Kma acetaldehyde/butyraldehyde 0.065 ± 0.005 mM/1.43 ± 0.16 mM
kcat acetaldehyde/butyraldehyde 141.44 ± 14.52 s−1/49.16 ± 3.8 s−1
kcat/Km acetaldehyde/butyraldehyde 2184 ± 393 mM−1 s−1/34 ± 7 mM−1 s−1
aThe kinetic constants were measured with appropriate concentrations of NADH and 
various concentrations of the corresponding substrate (acetaldehyde: 0.01–0.14 mM/
butyraldehyde 0.8–3 mM) in 100 mM HEPES pH 7 at 50°C.
FigUre 4 | effects of different conditions on the proline activity. (a) Temperature profile: the reactions were carried out at described conditions in a range 
from 40 to 90°C. (B) pH profile: the reactions were carried out at described conditions with following buffers: Δ, 50 mM MES buffer, pH 5.5–6.5; ●, 50 mM HEPES, 
pH 7–8; ×, 50 mM Taps, pH 9; ◆, 50 mM CAPS, pH 10. (c) Concentration-dependent activity: aldol condensation was determined in presence of various proline 
concentrations ranging from 1 to 500 mM. The scale is logarithmic.
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nearly 0.01 μmol min−1 mL−1, which is comparable to a different 
cell-free approach reported by the Ohtake group (Krutsakorn 
et al., 2013). After 4 h, the n-butanol production rate decreased 
and finally sized at 8  h. En route to n-butanol formation we 
could detect acetaldehyde, crotonaldehyde, and butyraldehyde as 
intermediates, which were almost completely consumed after 8 h.
In addition to n-butanol, we could also detect significant 
ethanol formation (c = 4.9 ± 0.0 mM) as a reaction byproduct. As 
shown in Table 3, ADH showed a strong substrate preference for 
acetaldehyde over butyraldehyde, which lead to an unfavorable 
substrate flux. Hence, the ADH reaction limited the acetaldehyde 
and the subsequent intermediate pools.
DiscUssiOn
The focus of this study was the design of an in vitro thermostable, 
biocatalytic reaction cascade that provides for the conversion of 
pyruvate to n-butanol with minimal enzyme activities and in the 
absence of any CoA-dependent intermediates. What is more, the 
reaction cascade should be modularly compatible with our previ-
ously reported in vitro production toolbox for the production of 
industrial solvents (Guterl et al., 2012).
This toolbox utilizes an artificial glycolytic reaction cascade. 
While the in vitro production of ethanol and isobutanol have been 
successfully reported previously (Guterl et al., 2012), designing a 
cell-free enzyme cascade for n-butanol was challenging particu-
larly with respect to harmonizing enzyme activities and cofactor 
concentrations.
To circumvent these limitations and reduce required enzyme 
activities, we designed a new biocatalytic n-butanol pathway. 
Our consolidated n-butanol production pathway operates with 
only three enzyme activities, NADH as the sole redox mediator 
and an amino acid catalyzed enamine–aldol condensation as the 
essential biocatalytic component that enables a C–C bond forma-
tion leading to the required C4 building block.
In the first proof-of-concept experiment, we could success-
fully produce 2 mM n-butanol, which corresponds to 148 mg L−1. 
Even with this prototypic approach, we could already achieve a 
60-fold increase of the n-butanol yield compared with a recently 
reported cell-based route utilizing an engineered Saccharomyces 
cerevisiae (2.5 mg L−1) system (Steen et al., 2008). Nevertheless, 
recent studies present much higher n-butanol titer for cell-based 
approaches. The native n-butanol producer C. acetobutylicum 
achieved ~12 g L−1 (Harris et al., 2001; Lee et al., 2008), while dif-
ferent mutants reached 17.6 g L−1 (Jang et al., 2013) and 18.6 g L−1, 
respectively (Formanek et  al., 1997). Engineered E. coli strains 
FigUre 5 | n-Butanol biosynthesis via the proline-catalyzed 
enamine–aldol condensation. n-Butanol production time profile. The 
reaction was carried out in 2 mL GC vials, without stirring at 50°C and neutral 
pH. ■, Pyruvate; , Acetaldehyde; ▲, Crotonaldehyde; ▽, Butyraldehyde; 
◆, n-Butanol. Note that the concentration of pyruvate and acetaldehyde was 
halved due to a better comparison with n-butanol concentration (2 mol 
pyruvate is converted to 1 mol n-butanol).
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produced n-butanol with a broad product titer spectrum, ranging 
from ~500 mg L−1 (Atsumi et al., 2008; Nielsen et al., 2009) to 
30 g L−1 (Shen et al., 2011). Compared with the cell-based achieved 
titer, our current in vitro system requires further improvements.
Using the first principles approach for optimization of our 
cell-free n-butanol cascade, we compared the kinetic proper-
ties of the required enzyme activities. With the exception of 
YqjM, kinetic properties for all other enzyme activities could 
be extracted from reference data. The exact kinetic properties 
of YqjM under aerobe conditions could not be determined due 
to side-reactions with molecular oxygen, which led to a non-
productive reduction of the NADH pool (Sommer et al., 2013b). 
Therefore, experimental optimization procedures were based on 
ADH and PDC kinetic data.
The ADH kcat for acetaldehyde (141.44 s−1) was 10-fold higher 
than for butyraldehyde (49.16  s−1) (Table  3) and the PDC kcat 
for pyruvate (113  s−1) was in a similar order of magnitude to 
the corresponding ADH value for butyraldehyde (Chang et al., 
2000). Considering the proline reaction rate at neutral pH and 
50°C, we therefore restricted the enzyme activities initially to half 
of the proline reaction rate. The activities were therefore set to 
0.25 U mL−1, while proline was set to 0.5 U mL−1 (Reaction 1). 
However, this approach led only to 0.8  mM n-butanol (Figure 
S1 in Supplementary Material). Finally, the reaction with the 
opposite combination of the enzyme activities (0.5 U mL−1) and 
proline reaction rate (0.25 U mL−1) led to the best result of 2 mM 
n-butanol.
The collective data in this study indicate two factors currently 
limiting n-butanol formation. A primary engineering target 
would be substrate preference of the ADH activity, as the kinetic 
properties showed a strong preference of acetaldehyde instead of 
butyraldehyde as a substrate, which results in undesired ethanol 
(4.9  mM) production, thereby reducing the n-butanol yield. 
However, acetaldehyde is an essential upstream intermediate of 
the n-butanol pathway and cannot be substituted. Therefore, a 
new or engineered ADH activity that favors higher aldehydes 
would be advantageous. As there are currently no ADH variants 
with increased butyraldehyde selectivity available, an extensive 
mutagenesis project possibly in combination with high content 
activity screening is required to generate the required enzyme 
activity.
Further pathway improvement could be achieved by replac-
ing proline with a synthetic analog that provides even higher 
reaction rates at neutral pH and lower temperatures. However, 
this approach requires extended chemical synthesis and kinetic 
studies that are beyond the scope of study. Similarly, the issue 
of the long-term stability of the redox cofactor NADH still 
remains, which also could be solved by substituting NADH with 
a synthetic analogous of higher reactivity and stability (Kaufman, 
1998; Ansell and Lowe, 1999; Oohora and Hayashi, 2014). The 
addition of alternative catalysts to enhance the reaction rate is 
therefore principally possible but has to be harmonized with the 
remaining enzyme activities of our designed reaction cascade.
Nonetheless, our cell-free n-butanol production route com-
pares well with previously reported in vitro n-butanol technolo-
gies. For instance, the n-butanol production route reported by the 
Ohtake group applied almost the entire clostridial biosynthesis 
pathway. This pathway was reconstructed in  vitro with a final 
n-butanol titer of 260 mg L−1 (Krutsakorn et al., 2013). To convert 
pyruvate to n-butanol, this approach required seven enzymes and 
two metabolic cofactors (NADH and CoA).
In contrast, our condensed in vitro concept requires only three 
enzymes, NADH as single cofactor and achieved 148  mg  L−1 
with a similar initial production rate of 0.01 μmol min−1 mL−1. 
Additionally, the combined biocatalytic n-butanol production 
pathway eliminates the need for any intermediate titration. 
Moreover, this pathway can be excellently integrated into our 
previously reported enzyme toolbox for in vitro solvent produc-
tion (Guterl et al., 2012). A complete integration of the current 
reaction cascade would provide for direct conversion of glucose 
to n-butanol.
In summary, to complete our modular in  vitro system to 
produce industrial solvents, we could successfully show the pro-
duction of n-butanol via a new condensed pathway. Although the 
aldol condensation step restricted the overall reaction due to the 
limited reaction rate, we could compete with alternative cell-free 
n-butanol production concepts. The presented in vitro n-butanol 
production system demonstrates the capacity modern synthetic 
biotechnology methodologies and the synergies of chemoenzy-
matic technologies.
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